| Dr Kristen W Eckelhoff, PSYD | |
|
3111 S 70th St, Fort Smith, AR 72903-5017 | |
| (479) 452-6650 | |
| (479) 452-5847 |
| Full Name | Dr Kristen W Eckelhoff |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 18 Years |
| Location | 3111 S 70th St, Fort Smith, Arkansas |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003901604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 07-29P (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Arkansas Counseling And Guidance Center, Inc | 1355326174 | 26 |
News Archive
In partnership with local community health care agencies, three Kaiser Permanente Southern California Medical Centers, opened their doors this morning to perform a total of 67 outpatient surgeries as part of a region-wide Free Surgery Day.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Secretary of State Hillary Rodham Clinton met Thursday with Rep. Paul Ryan (R-Wis.), the new House Budget Committee chair, "to set out her objections to the House Republicans' deficit-cutting plans," the Financial Times reports. Obama administration officials and congressional Democrats argue that Republican's proposed budget cuts "will reduce U.S. influence throughout the world ... and cost lives in Africa and beyond," the newspaper writes in a story outlining the different perspectives over how far budget cuts should go.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-GSK3Rx and earned a $3 million milestone payment from GlaxoSmithKline.
› Verified 7 days ago
| Entity Name | Western Arkansas Counseling & Guidance Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326040692 PECOS PAC ID: 1355326174 Enrollment ID: O20040623001595 |
News Archive
In partnership with local community health care agencies, three Kaiser Permanente Southern California Medical Centers, opened their doors this morning to perform a total of 67 outpatient surgeries as part of a region-wide Free Surgery Day.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Secretary of State Hillary Rodham Clinton met Thursday with Rep. Paul Ryan (R-Wis.), the new House Budget Committee chair, "to set out her objections to the House Republicans' deficit-cutting plans," the Financial Times reports. Obama administration officials and congressional Democrats argue that Republican's proposed budget cuts "will reduce U.S. influence throughout the world ... and cost lives in Africa and beyond," the newspaper writes in a story outlining the different perspectives over how far budget cuts should go.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-GSK3Rx and earned a $3 million milestone payment from GlaxoSmithKline.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristen W Eckelhoff, PSYD 3111 S 70th St, Fort Smith, AR 72903-5017 Ph: (479) 452-6650 | Dr Kristen W Eckelhoff, PSYD 3111 S 70th St, Fort Smith, AR 72903-5017 Ph: (479) 452-6650 |
News Archive
In partnership with local community health care agencies, three Kaiser Permanente Southern California Medical Centers, opened their doors this morning to perform a total of 67 outpatient surgeries as part of a region-wide Free Surgery Day.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Secretary of State Hillary Rodham Clinton met Thursday with Rep. Paul Ryan (R-Wis.), the new House Budget Committee chair, "to set out her objections to the House Republicans' deficit-cutting plans," the Financial Times reports. Obama administration officials and congressional Democrats argue that Republican's proposed budget cuts "will reduce U.S. influence throughout the world ... and cost lives in Africa and beyond," the newspaper writes in a story outlining the different perspectives over how far budget cuts should go.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-GSK3Rx and earned a $3 million milestone payment from GlaxoSmithKline.
› Verified 7 days ago
Dr. Phillip W Barling, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-783-0445 Fax: 479-782-5883 | |
Dr. Robert L. Spray, Jr, PHD PA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3104 S 70th St, Suite #103, Fort Smith, AR 72903 Phone: 479-452-1658 Fax: 479-452-3865 | |
Mr. Charles Wayne Winkle, EDD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3111 S 70th St, Fort Smith, AR 72903 Phone: 479-452-6650 Fax: 479-452-5847 | |
Richard F Murphy Jr., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-783-0445 Fax: 479-782-5883 | |
Dr. Richard H Barrett Ii, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 5601 Duncan Rd, Fort Smith, AR 72903 Phone: 479-561-3144 Fax: 479-649-9515 | |
Patricia J Walz, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1401 S Waldron Rd Ste 206, Fort Smith, AR 72903 Phone: 479-785-1995 Fax: 479-308-3971 |